JPWO2023146892A5 - - Google Patents
Info
- Publication number
- JPWO2023146892A5 JPWO2023146892A5 JP2024544865A JP2024544865A JPWO2023146892A5 JP WO2023146892 A5 JPWO2023146892 A5 JP WO2023146892A5 JP 2024544865 A JP2024544865 A JP 2024544865A JP 2024544865 A JP2024544865 A JP 2024544865A JP WO2023146892 A5 JPWO2023146892 A5 JP WO2023146892A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- compound
- pharmaceutically acceptable
- tautomer
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303197P | 2022-01-26 | 2022-01-26 | |
| US63/303,197 | 2022-01-26 | ||
| PCT/US2023/011515 WO2023146892A1 (en) | 2022-01-26 | 2023-01-25 | Biphenyl-substituted epithelial sodium channel blocking compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508335A JP2025508335A (ja) | 2025-03-26 |
| JPWO2023146892A5 true JPWO2023146892A5 (https=) | 2026-03-11 |
| JP2025508335A5 JP2025508335A5 (https=) | 2026-03-11 |
Family
ID=87472392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544865A Pending JP2025508335A (ja) | 2022-01-26 | 2023-01-25 | ビフェニル置換上皮性ナトリウムチャネル遮断化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250115561A1 (https=) |
| EP (1) | EP4469441A4 (https=) |
| JP (1) | JP2025508335A (https=) |
| KR (1) | KR20240153331A (https=) |
| CN (1) | CN119325465A (https=) |
| AU (1) | AU2023213626A1 (https=) |
| CA (1) | CA3249376A1 (https=) |
| IL (1) | IL314398A (https=) |
| MX (1) | MX2024009270A (https=) |
| WO (1) | WO2023146892A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025265075A1 (en) * | 2024-06-21 | 2025-12-26 | Parion Sciences, Inc. | Methods of clearing mucus from the lungs |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0526244D0 (en) * | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
| ES2485642T3 (es) * | 2008-02-26 | 2014-08-14 | Parion Sciences, Inc. | Bloqueantes poli-aromáticos de los canales de sodio |
| WO2016133967A2 (en) * | 2015-02-18 | 2016-08-25 | Parion Sciences, Inc. | Sodium channel blockers for skin disorders |
-
2023
- 2023-01-25 CA CA3249376A patent/CA3249376A1/en active Pending
- 2023-01-25 EP EP23747546.2A patent/EP4469441A4/en active Pending
- 2023-01-25 CN CN202380029362.0A patent/CN119325465A/zh active Pending
- 2023-01-25 US US18/832,903 patent/US20250115561A1/en active Pending
- 2023-01-25 JP JP2024544865A patent/JP2025508335A/ja active Pending
- 2023-01-25 AU AU2023213626A patent/AU2023213626A1/en active Pending
- 2023-01-25 IL IL314398A patent/IL314398A/en unknown
- 2023-01-25 KR KR1020247027958A patent/KR20240153331A/ko active Pending
- 2023-01-25 WO PCT/US2023/011515 patent/WO2023146892A1/en not_active Ceased
-
2024
- 2024-07-25 MX MX2024009270A patent/MX2024009270A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015129062A (ru) | Соединения 3, 5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида | |
| CN105228605B (zh) | 硫代糖粘液溶解剂 | |
| JP5611844B2 (ja) | 多環芳香族ナトリウムチャネル遮断薬 | |
| JP4805824B2 (ja) | キャップ化ピラジノイルグアニジンナトリウムチャネルブロッカー | |
| ES2392999T3 (es) | Bloqueadores de canales de sodio pirazinoilguanidina sustituida con fenilo que tienen actividad agonista beta | |
| JP2010502739A (ja) | ナトリウムチャネル阻害剤及び浸透圧調節物質を用いた処置による粘膜水和及び粘液クリアランスの改善 | |
| JP6596421B2 (ja) | ジチオール粘液溶解薬 | |
| JP2014518268A5 (https=) | ||
| RU2015129065A (ru) | Производные хлор-пиразинкарбоксамида, обладающие активностью блокирования эпителиальных натриевых каналов | |
| JP2010502738A (ja) | ナトリウムチャネル遮断剤および浸透圧調節物質での処置により粘膜水和および粘膜クリアランスを増強する方法 | |
| PT1461306E (pt) | Compostos de amónio quaternário | |
| WO2011160920A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
| HRP20100035T1 (hr) | Kristalni oblici bifenilnog spoja | |
| RU2015129076A (ru) | Арилалкил- и арилоксиалкил-замещенные соединения, блокирующие эпителиальный натриевый канал | |
| JP2024099568A (ja) | Ｓ－アポモルフィンの結晶形 | |
| US20110166149A1 (en) | Pteridine derivatives for treating respiratory disease | |
| JPWO2023146892A5 (https=) | ||
| JP2006504768A (ja) | 四級アンモニウム化合物 | |
| CA2573977A1 (en) | Nicotinic receptor agonists for the treatment of inflammatory diseases | |
| JP2006506402A (ja) | 四級アンモニウム化合物およびその抗ムスカリン薬としての使用 | |
| WO2020055916A9 (en) | Dithiolsaccharide mucolytic agents and uses thereof | |
| JP2006511494A (ja) | 抗ムスカリン剤としてのキヌクリジニウム誘導体 | |
| WO2025169996A1 (ja) | 化合物のアルカリ金属塩又はアルカリ土類金属塩 | |
| CN116730851A (zh) | 一种维兰特罗盐型化合物及其制备方法和用途 | |
| HK40089171A (zh) | 用於治疗病毒感染的瑞德西韦和瑞德西韦类似物、溶液剂以及纳米粒子、脂质体和微粒组合物 |